MRVI Deadline: MRVI Investors with Losses in Excess of $100K Have Opportunity to Lead Maravai Lifesciences Holdings, Inc. Securities Fraud Lawsuit
Provided By PR Newswire
Last update: Apr 30, 2025
NEW YORK, April 30, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds of purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025, both dates inclusive (the "Class Period"), of the important May 5, 2025 lead plaintiff deadline.
Read more at prnewswire.com
